Organon (OGN) Cash from Operations (2020 - 2026)

Organon has reported Cash from Operations for 7 years, with the latest figure at $107.0 million in Q2 2026.

• On a quarterly basis, Cash from Operations fell 51.36% year-over-year to $107.0 million in Q2 2026; TTM through Jun 2026 was $737.0 million, a 10.77% decrease from a year earlier, with the FY2025 full-year figure at $700.0 million, down 25.45% from the prior year.
• Cash from Operations was $107.0 million for Q2 2026 at Organon, down from $225.0 million in the prior quarter.
• The five-year high for Cash from Operations was $397.0 million in Q4 2023, with the low at $27.0 million in Q2 2023.
• Average Cash from Operations over 5 years is $201.6 million, with a median of $185.5 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Cash from Operations sank 90.54% in 2022, then jumped 1129.63% in 2024.
• Over 5 years, Cash from Operations stood at $267.0 million in 2022, then soared by 48.69% to $397.0 million in 2023, then retreated by 1.76% to $390.0 million in 2024, then plunged by 63.85% to $141.0 million in 2025, then slipped by 24.11% to $107.0 million in 2026.
• The last three Cash from Operations figures came in at $107.0 million (Q2 2026), $225.0 million (Q1 2026), and $141.0 million (Q4 2025), per Business Quant data.